abstract |
The pharmaceutical preparation of the present invention comprises an alkyl sulfate salt and a compound represented by the following formula (I) or a tautomer thereof, or a pharmaceutically acceptable salt thereofnâ–¡n(wherein, R1 to R4 are defined as contained in the specification). |